Tech Transfer eNews Blog
Industry-Sponsored Research Management sample issue

Indiana Biosciences Research Institute partners with four universities in the state to speed commercialization

By Jesse Schwartz
Published: September 13th, 2017

The Indiana Biosciences Research Institute (IBRI) has partnered with four Indiana universities to license available life sciences technologies at pre-defined terms. Ball State University, Indiana University, Purdue University, and the University of Notre Dame have signed onto the agreement.

The deal will give IBRI faster access to available technologies from the schools that can be combined with its own research to create synergies and help commercialize technologies more quickly.

 “With this arrangement in place, the IBRI will be able to unlock the value of discoveries being made at the state’s top research universities by further developing them or combining them with other technologies and bringing treatments to patients and innovations quicker to market,” said IBRI Chief Scientific and Innovation Officer and incoming CEO Rainer Fischer. “Successful commercialization will provide a return to the IBRI, to the universities that contributed intellectual property, and ultimately, to the State of Indiana in the form of economic growth.”

The MoU signed by the schools streamlines the licensing process accelerates the IBRI’s mission to bridge the gap between universities and industry. “The creation and work of the IBRI is a gift to the State of Indiana and its residents,” said Dan Hasler, Chief Entrepreneurial Officer of the Purdue Research Foundation. “This agreement sets the groundwork for stronger research and technology transfer collaboration among Indiana universities.”

The first technologies the institute will license include a mass spectrometry technology and a high sensitivity detection technology for single cell analysis developed at Purdue, and a microfluidic technology developed at Notre Dame.

 “IBRI is unique among research institutes in the country,” said Bryan Ritchie, Notre Dame’s vice president of innovation. “Not only will IBRI work to make new discoveries in the biosciences arena, but it will facilitate the collaboration and engagement of all the major bioscience players in Indiana. In this new environment, the potential for larger, faster and more impactful commercialization outcomes is now much greater than it has ever been.”

 “Partnering with the IBRI and other outstanding research universities across Indiana to combine strengths and jointly promote our innovations benefits all of us,” said Indiana University Vice President for Engagement Bill Stephan. “Not only will we be able to more rapidly move innovations to market, we’ll also further enhance the state’s economic vitality and continue to distinguish Indiana as a life and bio-sciences leader.”

Source: GlobeNewswire

Industry-Sponsored Research Management is the first and only publication focused on helping universities attract and manage corporate research partnerships. Don’t miss another issue! CLICK HERE to subscribe to and save $100

Posted under: Tech Transfer e-News

Twitter Facebook Linkedin Pinterest Email

No Comments so far ↓

There are no comments yet...Kick things off by filling out the form below.

Leave a Comment